These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6325726)

  • 1. Serologic response of captive coyotes (Canis latrans Say) to canine parvovirus and accompanying profiles of canine coronavirus titers.
    Green JS; Bruss ML; Evermann JF; Bergstrom PK
    J Wildl Dis; 1984 Jan; 20(1):6-11. PubMed ID: 6325726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of pups with maternal derived antibody to modified-live canine parvovirus vaccine.
    Buonavoglia C; Tollis M; Buonavoglia D; Puccini A
    Comp Immunol Microbiol Infect Dis; 1992 Oct; 15(4):281-3. PubMed ID: 1330425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization of pups with maternally derived antibodies to canine parvovirus (CPV) using a modified-live variant (CPV-2b).
    Pratelli A; Cavalli A; Normanno G; De Palma MG; Pastorelli G; Martella V; Buonavoglia C
    J Vet Med B Infect Dis Vet Public Health; 2000 May; 47(4):273-6. PubMed ID: 10861195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternally derived immunity to canine parvovirus infection: transfer, decline, and interference with vaccination.
    Pollock RV; Carmichael LE
    J Am Vet Med Assoc; 1982 Jan; 180(1):37-42. PubMed ID: 7056660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological survey for diseases in free-ranging coyotes (Canis latrans) in Yellowstone National Park, Wyoming.
    Gese EM; Schultz RD; Johnson MR; Williams ES; Crabtree RL; Ruff RL
    J Wildl Dis; 1997 Jan; 33(1):47-56. PubMed ID: 9027690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of selected canine vaccines for their ability to induce protective immunity against canine parvovirus infection.
    Larson LJ; Schultz RD
    Am J Vet Res; 1997 Apr; 58(4):360-3. PubMed ID: 9099379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of a low-passage, high-titer modified live canine parvovirus vaccine in pups with maternally derived antibodies.
    Hoare CM; DeBouck P; Wiseman A
    Vaccine; 1997 Feb; 15(3):273-5. PubMed ID: 9139485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of two canine parvovirus vaccines for inducing seroconversion in Rottweiler and Doberman pinscher pups with various levels of maternally derived antibodies.
    Coyne MJ
    Vet Ther; 2000; 1(1):35-42. PubMed ID: 19757563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal vaccination of pups in the presence of maternally derived antibodies to canine parvovirus (CPV). Evaluation of minimal immunizing dose.
    Buonavoglia C; Cavalli A; Tempesta M; Voight V; Buonavoglia D; Corrente M; Sagazio P
    New Microbiol; 1995 Oct; 18(4):371-5. PubMed ID: 8590389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of pups to modified-live canine parvovirus component in a combination vaccine.
    O'Brien SE; Roth JA; Hill BL
    J Am Vet Med Assoc; 1986 Apr; 188(7):699-701. PubMed ID: 3700224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serologic response of pups to the low-passage, modified-live canine parvovirus-2 component in a combination vaccine.
    O'Brien SE
    J Am Vet Med Assoc; 1994 Apr; 204(8):1207-9. PubMed ID: 8014088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal vaccination of pups with maternally derived antibodies with a modified live canine parvovirus.
    Buonavoglia C; Cavalli A; Gravino E; Voigt V; Buonavoglia D; de Caprariis D
    Zentralbl Veterinarmed B; 1994 Mar; 41(1):3-8. PubMed ID: 7941844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A modified live canine parvovirus vaccine. II. Immune response.
    Carmichael LE; Joubert JC; Pollock RV
    Cornell Vet; 1983 Jan; 73(1):13-29. PubMed ID: 6337780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of puppies to canine-origin parvovirus vaccines.
    Carmichael LE; Pollock RV; Joubert JC
    Mod Vet Pract; 1984 Feb; 65(2):99-102. PubMed ID: 6328258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination of dogs with canine parvovirus type 2b (CPV-2b) induces neutralising antibody responses to CPV-2a and CPV-2c.
    Wilson S; Illambas J; Siedek E; Stirling C; Thomas A; Plevová E; Sture G; Salt J
    Vaccine; 2014 Sep; 32(42):5420-4. PubMed ID: 25148778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of maternal antibody decay and response to canine parvovirus vaccination using a clinic-based enzyme-linked immunosorbent assay.
    Waner T; Naveh A; Wudovsky I; Carmichael LE
    J Vet Diagn Invest; 1996 Oct; 8(4):427-32. PubMed ID: 8953526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experiments with a homologous, inactivated canine parvovirus vaccine in vaccination programmers for dogs.
    Wilson JH; Hermann-Dekkers WM
    Vet Q; 1982; 4(3):108-16. PubMed ID: 6293155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of antibodies against canine parvovirus and canine distemper virus in wild coyotes in southeastern Colorado.
    Gese EM; Schultz RD; Rongstad OJ; Andersen DE
    J Wildl Dis; 1991 Apr; 27(2):320-3. PubMed ID: 1648628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of vaccination at 4 and 6 weeks in the control of canine parvovirus.
    De Cramer KG; Stylianides E; van Vuuren M
    Vet Microbiol; 2011 Apr; 149(1-2):126-32. PubMed ID: 21111542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of canine parvovirus in wild coyotes from Texas, Utah, and Idaho (1972 to 1983).
    Thomas NJ; Foreyt WJ; Evermann JF; Windberg LA; Knowlton FF
    J Am Vet Med Assoc; 1984 Dec; 185(11):1283-7. PubMed ID: 6096323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.